Skip to main content
. 2014 Aug 21;78(3):556–564. doi: 10.1111/bcp.12368

Table 1.

Pharmacodynamic effects of loperamide by co-administered drug

Period Co-administered drug Dose, mg Number of subjects AUEC of change in pupil diameter (mm*h) AUEC of alertness score (VAS score*h) AUEC of oxygen saturation (%*h)
1 None NA 18 −19.7 ± 26.7 944.7 ± 694.7 4684.5 ± 27.1
2 Quinidine 600 18 −44.4 ± 35.3 945.7 ± 619.2 4698.9 ± 31.5
3 HM30181 15 6 −24.2 ± 32.3 767.8 ± 309.5 4711.9 ± 20.6
60 6 1.4 ± 13.4 794.6 ± 832.8 4713.0 ± 24.3
180 6 −11.4 ± 13.2 1166.0 ± 701.9 4717.5 ± 39.2
All 18 −11.4 ± 23.0* 909.4 ± 641.9 4714.1 ± 27.5*,

Data are mean ± SD. AUEC (the area under the effect–time curve),

*

P < 0.05 vs. quinidine co-administration;

P < 0.05 vs. loperamide alone.